Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, Tatsuya Ioka et al.|Journal of Clinical Oncology|2013Cited by 632
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like CellsJun Sunayama, Chifumi Kitanaka, Kenichiro Matsuda et al.|Stem Cells|2010Cited by 219
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 AxisAtsushi Satō, Chifumi Kitanaka, Jun Sunayama et al.|Stem Cells|2011Cited by 125
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cellsJun Sunayama, Chifumi Kitanaka, Atsushi Satō et al.|Neuro-Oncology|2010Cited by 100
Targeting JNK for therapeutic depletion of stem-like glioblastoma cellsKenichiro Matsuda, Chifumi Kitanaka, Atsushi Satō et al.|Scientific Reports|2012Cited by 95